Evidence network for deaths_(OS)

4NCI E3805 (Scott), 2017 STAMPEDE docetaxel, 2016 CHAARTED, 0 GETUG-AFU 15, 20132ARASENS , 2022 PEACE-1, 20225LATITUDE, 2019 TITAN, 2019 ENZAMET, 2019 STAMPEDE abiraterone, 2017 ARCHES, 2022docetaxel plus ADTandrogen deprivation therapy (ADT)darolutamide plus doxetaxel plus ADTabiraterone plus ADTenzalutamide plus ADTabiraterone plus docetaxel plus ADTapalutamide plus ADTdirect evidencenetwork meta-analysis
T vs. C docetaxel plus ADTandrogen deprivation therapy (ADT)darolutamide plus doxetaxel plus ADTabiraterone plus ADTenzalutamide plus ADTabiraterone plus docetaxel plus ADTapalutamide plus ADT
docetaxel plus ADT---NANANANANANA
androgen deprivation therapy (ADT)NA---NANANANANA
darolutamide plus doxetaxel plus ADTNANA---NANANANA
abiraterone plus ADTNANANA---NANANA
enzalutamide plus ADTNANANANA---NANA
abiraterone plus docetaxel plus ADTNANANANANA---NA
apalutamide plus ADTNANANANANANA---

pathologies: 332 - treatments: 1352 result logic